XJPX
4526
Market cap571mUSD
Oct 09, Last price
3,135.00JPY
1D
1.46%
1Q
0.00%
Jan 2017
32.56%
Name
Riken Vitamin Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Riken Vitamin Co., Ltd., based in Tokyo, Japan, operates across several key sectors: food ingredients, food applications, healthcare, and chemicals. The company provides a diverse portfolio of food additives, including emulsifiers used in a wide array of products such as baked goods (bread, cake), desserts (whipped topping, ice cream), dairy items (coffee cream, margarine), and other food preparations like tofu, jam, marmalade, cocoa, chocolate, noodles, and mashed potatoes. A specific offering is distilled diglycerine ester, a compound resulting from the interaction of diglycerine with fatty acids. To prolong shelf life, Riken Vitamin supplies natural tocopherol, an antioxidant that prevents oxidation and maintains food freshness. Their product line further encompasses natural food colors and various flavorings suitable for seasoning seafood, poultry, and beef. The company also deals in wakame seaweed, frequently utilized in soups, salads, and instant noodle preparations, alongside integrated stabilizing and emulsifying solutions for frozen treats and dairy products. Additionally, they develop specialized bakery emulsifiers, bread improvers, and cake-enhancing agents. In the chemical realm, Riken Vitamin offers various improving agents, including glycerol, polyglycerol, sorbitan, propylene glycol, and other specialty esters, in addition to vitamins. Established in 1917, the company was initially known as Riken Vitamin Oil Co., Ltd. before rebranding as Riken Vitamin Co., Ltd. in 1980.
Key people
Tsutomu Mochizuki
President, Representative Director · since 2025
Takumi Aoki
Managing Executive Officer · since 2024
Shinichi Koyama
Managing Executive Officer · since 2021
Masaaki Nakano
Managing Executive Officer · since 2024
Takeo Yotsuka
Managing Executive Officer · since 2025
Yasunori Iwasa
Executive Officer, Chief Director of Household Foods Sales · since 2023
Tomoya Sato
Executive Officer, Chief Director of Processed Foods Sales · since 2024
Toshiyuki Tanaka
Executive Officer, Director of Human Resources · since 2021
Seiji Akutsu
Executive Officer, Chief Director of Wide Area Sales, Director of Sales Promotion · since 2024
Atsushi Fujimori
Executive Officer, Manager of Grass Processing Plant · since 2021
Tadashi Hasebe
Executive Officer, Senior Chief Director of Production, Director of Production Administration · since 2025
Tomonaga Horikawa
Executive Officer, Director of Chemical Products Business · since 2025
Toru Isoda
Executive Officer, Chief Director of Production Promotion, Director of Production Technology · since 2025
Noriyuki Kawasaki
Executive Officer, Chief Director of Food Products Sales · since 2025
Hiromi Kimura
Executive Officer · since 2025
Tsuyoshi Kitagawa
Executive Officer, Director of Food Improver Development · since 2022
Yasuhiko Kondo
Executive Officer, Director of Healthcare Business · since 2022
Wataru Minami
Executive Officer, Senior Chief Director of International Affairs · since 2025
Toru Miyazawa
Executive Officer · since 2024
Takehiko Watanabe
Executive Officer, Director of Food Technology Development · since 2021
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||